##plugins.themes.academic_pro.article.main##

Abstract

Autism spectrum disorder is a neurodevelopmental condition with a wide range of symptoms. An early stage begins before the age of 3. Autistic people have trouble socializing, communicating verbally and nonverbally, as well as having stereotypical interests and behaviors. Due to the increasing frequency of autism in children and the lack of effective treatments, it is one of the most challenging conditions to treat in psychology. Autism has a perplexing etiology. Immune regulation of neuronal proliferation, synapse formation, and plasticity are all enhanced by the chemosensory immune system. Immune responses in autistic people are aberrant, according to hundreds of studies conducted over the past four decades. Vitamin D deficiency, as well as cytokine profile and signaling abnormalities, have become increasingly prevalent in recent years and have been the focus of continuing research in the field of autism spectrum disorder. Numerous studies indicate that vitamin D plays a significant role as a neuroactive steroid that can influence neuronal development, axonal connections, and brain structure and function. In addition, vitamin D insufficiency during pregnancy is associated with a number of negative effects on the fetus. Immune abnormalities have previously been identified, and the role of cytokines in these abnormalities is highlighted in this review, which aims to determine whether cytokines are useful as potential biomarkers that may participate in the development of disease. The purpose of this review is to outline the function of the immune system and to examine the relationship between the immune biomarkers, cytokines with as emphasis on the role of vitamin D as an immune regulator.

Keywords

Autism spectrum disorder autism severity pathogenesis immune

##plugins.themes.academic_pro.article.details##

How to Cite
Jehan Yawez Al-Demirchi, & Batool Hassan Al Ghurabi. (2022). Potential Role of Cytokines and Vitamin D in Pathophysiology of Autism Spectrum Disorder. Texas Journal of Medical Science, 11, 1–13. https://doi.org/10.62480/tjms.2022.vol11.pp1-13

References

  1. WT, Chang C, Gershwin ME, Lian ZX. Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review. Journal of autoimmunity. 2017 Sep 1;83:95-112. doi: 10.1016/j.jaut.2017.07.003
  2. -Warren RP, Margaretten NC, Pace NC, Foster A. Immune abnormalities in patients with autism. Journal of autism and developmental disorders. 1986 Jun;16(2):189-97.
  3. -Careaga M, Ashwood P. Autism spectrum disorders: from immunity to behavior. InPsychoneuroimmunology 2012 (pp. 219-240). Humana Press, Totowa, NJ.
  4. -Heuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, Hertz‐Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Research. 2008 Oct;1(5):275-83.
  5. -Enstrom A, Krakowiak P, Onore C, Pessah IN, Hertz-Picciotto I, Hansen RL, Van de Water JA, Ashwood P. Increased IgG4 levels in children with autism disorder. Brain, behavior, and immunity. 2009 Mar 1;23(3):389-95.
  6. -Zaman S, Yazdani U, Deng Y, Li W, Gadad BS, Hynan L, Karp D, Roatch N, Schutte C, Nathan Marti C, Hewitson L. A search for blood biomarkers for autism: peptoids. Scientific reports. 2016 Jan 14;6(1):1-8.
  7. -Molloy CA, Morrow AL, Meinzen-Derr J, Dawson G, Bernier R, Dunn M, Hyman SL, McMahon WM, Goudie-Nice J, Hepburn S, Minshew N. Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study. Journal of autism and developmental disorders. 2006 Apr;36(3):317-24.
  8. -Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, behavior, and immunity. 2011 Jan 1;25(1):40-5.
  9. -Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain, behavior, and immunity. 2010 Jan 1;24(1):64-71.
  10. -Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, Archer T. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotoxicity research. 2013 Nov;24(4):491-501.
  11. -Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N. Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis. Cytokine. 2019 Nov 1;123:154740.
  12. -Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology. 2006 Oct;31(10):2121-31.
  13. -Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH. Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior. Molecular psychiatry. 2010 May;15(5):535-47.
  14. -Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biological psychiatry. 2010 Mar 1;67(5):446-57.
  15. -Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013 Dec 19;155(7):1451-63.
  16. -Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biological psychiatry. 2013 Jul 1;74(1):15-25.
  17. -Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2005 Jan;57(1):67-81.
  18. -Ratajczak HV. Theoretical aspects of autism: biomarkers—a review. Journal of immunotoxicology. 2011 Mar 1;8(1):80-94.
  19. - Napolioni V, Ober-Reynolds B, Szelinger S, Corneveaux JJ, Pawlowski T, Ober-Reynolds S, Kirwan J, Persico AM, Melmed RD, Craig DW, Smith CJ. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. Journal of neuroinflammation. 2013 Dec;10(1):1-2. doi: 10.1186/1742-2094-10-38
  20. -Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, Van de Water J. Neonatal cytokine profiles associated with autism spectrum disorder. Biological psychiatry. 2017 Mar 1;81(5):442-51. doi: 10.1016/j.biopsych.2015.08.007
  21. - Mazahery H, Camargo Jr CA, Conlon C, Beck KL, Kruger MC, Von Hurst PR. Vitamin D and autism spectrum disorder: a literature review. Nutrients. 2016 Apr 21;8(4):236.. doi: 10.3390/nu8040236
  22. -Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics. 2015 Jan;135(1):e196-8. doi: 10.1542/peds.2014-2121
  23. -Azzam HM, Sayyah H, Youssef S, Lotfy H, Abdelhamid IA, Abd Elhamed HA, Maher S. Autism and vitamin D: An intervention study. Middle East Current Psychiatry. 2015 Jan 1;22(1):9-14. doi: 10.1097/01.Xme.0000457269.05570.78
  24. -Saad K, Abdel‐Rahman AA, Elserogy YM, Al‐Atram AA, El‐Houfey AA, Othman HA, Bjørklund G, Jia F, Urbina MA, Abo‐Elela MG, Ahmad FA. Retracted: Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. Journal of Child Psychology and Psychiatry. 2018 Jan;59(1):20-9. doi: 10.1111/jcpp.12652
  25. -Feng J, Shan L, Du L, Wang B, Li H, Wang W, Wang T, Dong H, Yue X, Xu Z, Staal WG. Clinical improvement following vitamin D3 supplementation in autism spectrum disorder. Nutritional neuroscience. 2017 May 28;20(5):284-90. doi: 10.1080/1028415x.2015.1123847